Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Optimum Detection of Ureaplasma in Premature Infants.

Brand MC, Mandy GT, Arora S, Castro EC, Gordon PS, Hagan JL, Zodin AL, Weisman LE.

Pediatr Infect Dis J. 2018 Dec;37(12):1294-1298. doi: 10.1097/INF.0000000000001994.

PMID:
29634623
2.

Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity.

Israel L, Wang Y, Bulek K, Della Mina E, Zhang Z, Pedergnana V, Chrabieh M, Lemmens NA, Sancho-Shimizu V, Descatoire M, Lasseau T, Israelsson E, Lorenzo L, Yun L, Belkadi A, Moran A, Weisman LE, Vandenesch F, Batteux F, Weller S, Levin M, Herberg J, Abhyankar A, Prando C, Itan Y, van Wamel WJB, Picard C, Abel L, Chaussabel D, Li X, Beutler B, Arkwright PD, Casanova JL, Puel A.

Cell. 2017 Feb 23;168(5):789-800.e10. doi: 10.1016/j.cell.2017.01.039.

3.

Late-onset sepsis in preterm infants: update on strategies for therapy and prevention.

Pammi M, Weisman LE.

Expert Rev Anti Infect Ther. 2015 Apr;13(4):487-504. doi: 10.1586/14787210.2015.1008450. Epub 2015 Feb 8. Review.

PMID:
25661566
4.

Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.

Munoz FM, Weisman LE, Read JS, Siberry G, Kotloff K, Friedman J, Higgins RD, Hill H, Seifert H, Nesin M.

Clin Infect Dis. 2014 Dec 15;59 Suppl 7:S415-27. doi: 10.1093/cid/ciu727.

5.

Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse.

Weisman LE, Leeming AH, Kong L.

Pediatr Res. 2012 Nov;72(5):502-6. doi: 10.1038/pr.2012.115. Epub 2012 Aug 20.

PMID:
22907617
6.

Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units.

Pammi M, Eddama O, Weisman LE.

Cochrane Database Syst Rev. 2011 Nov 9;(11):CD006068. doi: 10.1002/14651858.CD006068.pub3. Review.

PMID:
22071827
7.

A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.

Weisman LE, Thackray HM, Steinhorn RH, Walsh WF, Lassiter HA, Dhanireddy R, Brozanski BS, Palmer KG, Trautman MS, Escobedo M, Meissner HC, Sasidharan P, Fretz J, Kokai-Kun JF, Kramer WG, Fischer GW, Mond JJ.

Pediatrics. 2011 Aug;128(2):271-9. doi: 10.1542/peds.2010-3081. Epub 2011 Jul 25.

PMID:
21788224
8.

Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease.

Lin FY, Weisman LE, Azimi P, Young AE, Chang K, Cielo M, Moyer P, Troendle JF, Schneerson R, Robbins JB.

Pediatr Infect Dis J. 2011 Sep;30(9):759-63. doi: 10.1097/INF.0b013e31821dc76f.

9.

Respiratory syncytial virus (RSV) prevention and treatment: past, present, and future.

Weisman LE.

Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):223-33. Review.

PMID:
19689261
10.

Guidelines on CMV congenital infection.

Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, Greenough A, Gibbs RS, Carbonell-Estrany X; WAPM Perinatal Infections Working Group.

J Perinat Med. 2009;37(5):433-45. doi: 10.1515/JPM.2009.127.

PMID:
19673682
11.

Antibiotic prophylaxis improves Ureaplasma-associated lung disease in suckling mice.

Walls SA, Kong L, Leeming HA, Placencia FX, Popek EJ, Weisman LE.

Pediatr Res. 2009 Aug;66(2):197-202. doi: 10.1203/PDR.0b013e3181aabd34.

PMID:
19390479
12.

Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.

Weisman LE, Thackray HM, Garcia-Prats JA, Nesin M, Schneider JH, Fretz J, Kokai-Kun JF, Mond JJ, Kramer WG, Fischer GW.

Antimicrob Agents Chemother. 2009 Jul;53(7):2879-86. doi: 10.1128/AAC.01565-08. Epub 2009 Apr 20.

13.

Motavizumab, a second-generation humanized mAb for the prevention of respiratory syncytial virus infection in high-risk populations.

Weisman LE.

Curr Opin Mol Ther. 2009 Apr;11(2):208-18. Erratum in: Curr Opin Mol Ther. 2009 Jun;11(3):346-7.

PMID:
19330726
14.

Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults.

Weisman LE, Fischer GW, Thackray HM, Johnson KE, Schuman RF, Mandy GT, Stratton BE, Adams KM, Kramer WG, Mond JJ.

Int Immunopharmacol. 2009 May;9(5):639-44. doi: 10.1016/j.intimp.2009.02.008. Epub 2009 Mar 5.

PMID:
19268719
15.

Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.

Placencia FX, Kong L, Weisman LE.

Pediatr Res. 2009 Apr;65(4):420-4. doi: 10.1203/PDR.0b013e3181994a53.

PMID:
19127212
16.

Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999.

Bohnsack JF, Whiting A, Gottschalk M, Dunn DM, Weiss R, Azimi PH, Philips JB 3rd, Weisman LE, Rhoads GG, Lin FY.

J Clin Microbiol. 2008 Apr;46(4):1285-91. doi: 10.1128/JCM.02105-07. Epub 2008 Feb 20.

17.

Treatment and prevention of malaria in pregnancy and newborn.

Coll O, Menendez C, Botet F, Dayal R; World Association of Perinatal Medicine Perinatal Infections Working Group, Carbonell-Estrany X, Weisman LE, Anceschi MM, Greenough A, Gibss RS, Ville Y.

J Perinat Med. 2008;36(1):15-29. doi: 10.1515/JPM.2008.002.

PMID:
18184095
18.

Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection.

Venkatesh MP, Pham D, Kong L, Weisman LE.

Adv Ther. 2007 Sep-Oct;24(5):941-54.

PMID:
18029319
19.
20.
21.

Lysostaphin in treatment of neonatal Staphylococcus aureus infection.

Oluola O, Kong L, Fein M, Weisman LE.

Antimicrob Agents Chemother. 2007 Jun;51(6):2198-200. Epub 2007 Apr 9.

22.

Neonatal coinfection model of coagulase-negative Staphylococcus (Staphylococcus epidermidis) and Candida albicans: fluconazole prophylaxis enhances survival and growth.

Venkatesh MP, Pham D, Fein M, Kong L, Weisman LE.

Antimicrob Agents Chemother. 2007 Apr;51(4):1240-5. Epub 2007 Jan 29.

23.

Coagulase-negative staphylococcal infections in the neonate and child: an update.

Venkatesh MP, Placencia F, Weisman LE.

Semin Pediatr Infect Dis. 2006 Jul;17(3):120-7. Review.

PMID:
16934706
24.

Prevention and treatment of respiratory syncytial virus infection in infants: an update.

Venkatesh MP, Weisman LE.

Expert Rev Vaccines. 2006 Apr;5(2):261-8. Review.

PMID:
16608425
25.

Phylogenetic lineages of invasive and colonizing strains of serotype III group B Streptococci from neonates: a multicenter prospective study.

Lin FY, Whiting A, Adderson E, Takahashi S, Dunn DM, Weiss R, Azimi PH, Philips JB 3rd, Weisman LE, Regan J, Clark P, Rhoads GG, Frasch CE, Troendle J, Moyer P, Bohnsack JF.

J Clin Microbiol. 2006 Apr;44(4):1257-61.

26.

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.

Lin FY, Weisman LE, Azimi PH, Philips JB 3rd, Clark P, Regan J, Rhoads GG, Frasch CE, Gray BM, Troendle J, Brenner RA, Moyer P, Clemens JD.

J Infect Dis. 2004 Sep 1;190(5):928-34. Epub 2004 Jul 28.

PMID:
15295698
27.

Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient.

Weisman LE.

Curr Opin Infect Dis. 2004 Jun;17(3):237-41. Review.

PMID:
15166827
28.

Dexamethasone effects on group B streptococcal infection in newborn rats.

Tran TV, Weisman LE.

Pediatr Infect Dis J. 2004 Jan;23(1):47-52.

PMID:
14743046
29.

Prematurity is the major risk factor for late-onset group B streptococcus disease.

Lin FY, Weisman LE, Troendle J, Adams K.

J Infect Dis. 2003 Jul 15;188(2):267-71. Epub 2003 Jul 1.

PMID:
12854082
30.
31.

Current respiratory syncytial virus prevention strategies in high-risk infants.

Weisman LE.

Pediatr Int. 2002 Oct;44(5):475-80. Review.

PMID:
12225544
32.

Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.

Lin FY, Philips JB 3rd, Azimi PH, Weisman LE, Clark P, Rhoads GG, Regan J, Concepcion NF, Frasch CE, Troendle J, Brenner RA, Gray BM, Bhushan R, Fitzgerald G, Moyer P, Clemens JD.

J Infect Dis. 2001 Oct 15;184(8):1022-8. Epub 2001 Aug 31.

PMID:
11574917
33.

The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.

Lin FY, Brenner RA, Johnson YR, Azimi PH, Philips JB 3rd, Regan JA, Clark P, Weisman LE, Rhoads GG, Kong F, Clemens JD.

Am J Obstet Gynecol. 2001 May;184(6):1204-10.

PMID:
11349189
34.

Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.

Lin FY, Azimi PH, Weisman LE, Philips JB 3rd, Regan J, Clark P, Rhoads GG, Clemens J, Troendle J, Pratt E, Brenner RA, Gill V.

Clin Infect Dis. 2000 Jul;31(1):76-9. Epub 2000 Jul 24.

PMID:
10913400
35.

Immunoprophylaxis with palivizumab, a humanized respiratory syncytial virus monoclonal antibody, for prevention of respiratory syncytial virus infection in high risk infants: a consensus opinion.

Meissner HC, Welliver RC, Chartrand SA, Law BJ, Weisman LE, Dorkin HL, Rodriguez WJ.

Pediatr Infect Dis J. 1999 Mar;18(3):223-31. Review. No abstract available.

PMID:
10093942
36.

Treatment of obstructive jaundice in erythroblastosis fetalis with ursodeoxycholic acid (UDCA): a case report.

Perez EM, Cooper TR, Moise AA, Ferry GD, Weisman LE.

J Perinatol. 1998 Jul-Aug;18(4):317-9.

PMID:
9730206
37.

Actuarial survival in the premature infant less than 30 weeks' gestation.

Cooper TR, Berseth CL, Adams JM, Weisman LE.

Pediatrics. 1998 Jun;101(6):975-8.

PMID:
9606222
38.

Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection.

Lin FY, Clemens JD, Azimi PH, Regan JA, Weisman LE, Philips JB 3rd, Rhoads GG, Clark P, Brenner RA, Ferrieri P.

J Infect Dis. 1998 Mar;177(3):790-2.

PMID:
9498466
39.

Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group.

Subramanian KN, Weisman LE, Rhodes T, Ariagno R, Sánchez PJ, Steichen J, Givner LB, Jennings TL, Top FH Jr, Carlin D, Connor E.

Pediatr Infect Dis J. 1998 Feb;17(2):110-5.

PMID:
9493805
40.

Resource utilization among neonatologists in a university children's hospital.

Adams JM, Moreno J, Reynolds K, Campbell DW IV, Smith EO, Weisman LE.

Pediatrics. 1997 Jun;99(6):E2.

PMID:
9164798
41.

Novel approaches to the prevention and therapy of neonatal bacterial sepsis.

Perez EM, Weisman LE.

Clin Perinatol. 1997 Mar;24(1):213-29. Review.

PMID:
9099511
42.

Premature rupture of the membranes: neonatal consequences.

Merenstein GB, Weisman LE.

Semin Perinatol. 1996 Oct;20(5):375-80. Review.

PMID:
8912991
43.

Mature micromegakaryocytes: an unusual developmental pattern in term infants.

Levine RF, Olson TA, Shoff PK, Miller MK, Weisman LE.

Br J Haematol. 1996 Aug;94(2):391-9.

PMID:
8759904
44.

Teaching newborn medicine to third-year medical students. Use of a checklist.

McCurdy FA, Weisman LE.

Arch Pediatr Adolesc Med. 1995 Jan;149(1):49-52.

PMID:
7827660
45.

Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates.

Weisman LE, Stoll BJ, Kueser TJ, Rubio TT, Frank CG, Heiman HS, Subramanian KN, Hankins CT, Cruess DF, Hemming VG, et al.

J Pediatr. 1994 Dec;125(6 Pt 1):922-30.

PMID:
7996367
46.

Opsonic activity of commercially available standard intravenous immunoglobulin preparations.

Weisman LE, Cruess DF, Fischer GW.

Pediatr Infect Dis J. 1994 Dec;13(12):1122-5. Erratum in: Pediatr Infect Dis J 1995 May;14(5):349.

PMID:
7892082
47.

The safety of intravenous immunoglobulin preparations.

Weisman LE.

Isr J Med Sci. 1994 May-Jun;30(5-6):459-63. Review. No abstract available.

PMID:
8034504
48.

Advances in the treatment of neonatal sepsis and meningitis.

Weisman LE.

Isr J Med Sci. 1994 May-Jun;30(5-6):455-8. Review. No abstract available.

PMID:
8034503
49.

Opsonic antibodies to Staphylococcus epidermidis: in vitro and in vivo studies using human intravenous immune globulin.

Fischer GW, Cieslak TJ, Wilson SR, Weisman LE, Hemming VG.

J Infect Dis. 1994 Feb;169(2):324-9.

PMID:
8106765
50.

Acute asphyxia affects neutrophil number and function in the rat.

Beachy JC, Weisman LE.

Crit Care Med. 1993 Dec;21(12):1929-34.

PMID:
8252900

Supplemental Content

Loading ...
Support Center